Laurence Reid

Laurence Reid is a declared insider at 2 companies (chief executive); the most frequent names are Decibel Therapeutics, Inc. and Metagenomi Therapeutics, Inc. Over a trading history stretching from 15 September 2021 to 9 September 2026, the count stands at 5 filings.

No open-market sale appears; the market trades are 3 purchases worth €85k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant. So far in 2026, the count stands at 2 purchases and no sales.

Half of the purchases are above €20k and half below. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 11 September 2026 came the latest disclosure, an open-market purchase for €20k in Metagenomi Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.